Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.520
+0.050 (2.02%)
At close: Nov 22, 2024, 4:00 PM
2.500
-0.020 (-0.80%)
After-hours: Nov 22, 2024, 6:45 PM EST
Esperion Therapeutics Employees
Esperion Therapeutics had 240 employees as of December 31, 2023. The number of employees increased by 41 or 20.60% compared to the previous year.
Employees
240
Change (1Y)
41
Growth (1Y)
20.60%
Revenue / Employee
$1,231,046
Profits / Employee
-$361,546
Market Cap
496.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pacific Biosciences of California | 796 |
Treace Medical Concepts | 516 |
Pharming Group | 382 |
UroGen Pharma | 201 |
Korro Bio | 102 |
Semler Scientific | 92 |
PureTech Health | 90 |
Zevra Therapeutics | 69 |
ESPR News
- 4 days ago - Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024 - GlobeNewsWire
- 10 days ago - Esperion Therapeutics: Growth Initiatives Are Paying Off - Buy - Seeking Alpha
- 14 days ago - Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Esperion Therapeutics, Inc. (ESPR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 18 days ago - Esperion to Participate in Upcoming Jefferies London Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Esperion to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewsWire
- 2 months ago - Esperion Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire